Dexcom (DXCM) EBITDA Margin (2010 - 2026)
Dexcom (DXCM) reported EBITDA Margin of 21.42% for Q1 2026, up 851.0% year-over-year from 2.25% in Q1 2025, and down 16.47% on a QoQ basis from 25.64% in Q4 2025.
Dexcom (DXCM) has 17 years of EBITDA Margin data on file, last reported at 21.42% in Q1 2026.
- Quarterly EBITDA Margin rose 851.0% year-over-year to 21.42% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.45% (up 620.0% YoY) and the FY2025 annual result came in at 19.56%, up 468.0% from the prior year.
- EBITDA Margin declined to 21.42% in Q1 2026 per DXCM's latest filing, from 25.64% in the prior quarter.
- Across five years, EBITDA Margin topped out at 25.64% in Q4 2025 and bottomed at 6.37% in Q1 2023.
- The 5-year median for EBITDA Margin is 15.73% (2024), against an average of 16.04%.
- Peak annual rise in EBITDA Margin reached 1530 bps in 2022, while the deepest fall reached 591 bps in 2022.
- Tracing DXCM's EBITDA Margin over 5 years: stood at 15.38% in 2022, then soared by 36 bps to 20.97% in 2023, then decreased by 19 bps to 16.96% in 2024, then soared by 51 bps to 25.64% in 2025, then retreated by 16 bps to 21.42% in 2026.
- Per Business Quant, the three latest DXCM EBITDA Margin figures stand at 21.42% (Q1 2026), 25.64% (Q4 2025), and 20.05% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 17.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.42% |
| Dec 31, 2025 | 25.64% |
| Sep 30, 2025 | 20.05% |
| Jun 30, 2025 | 18.37% |
| Mar 31, 2025 | 12.91% |
| Dec 31, 2024 | 16.96% |
| Sep 30, 2024 | 15.29% |
| Jun 30, 2024 | 15.73% |
| Mar 31, 2024 | 10.98% |
| Dec 31, 2023 | 20.97% |
| Sep 30, 2023 | 21.08% |
| Jun 30, 2023 | 14.70% |
| Mar 31, 2023 | 6.37% |
| Dec 31, 2022 | 15.38% |
| Sep 30, 2022 | 19.17% |
| Jun 30, 2022 | 11.06% |
| Mar 31, 2022 | 6.57% |
| Dec 31, 2021 | 0.09% |
| Sep 30, 2021 | 18.19% |
| Jun 30, 2021 | 16.97% |
| Mar 31, 2021 | 9.09% |
| Dec 31, 2020 | 18.28% |
| Sep 30, 2020 | 18.79% |
| Jun 30, 2020 | 15.01% |
| Mar 31, 2020 | 8.29% |
| Dec 31, 2019 | 21.93% |
| Sep 30, 2019 | 14.13% |
| Jun 30, 2019 | -0.24% |
| Mar 31, 2019 | -5.13% |
| Dec 31, 2018 | -48.70% |
| Sep 30, 2018 | 5.21% |
| Jun 30, 2018 | -2.02% |
| Mar 31, 2018 | -16.65% |
| Dec 31, 2017 | 5.43% |
| Sep 30, 2017 | -0.27% |
| Jun 30, 2017 | -7.97% |
| Mar 31, 2017 | -28.39% |
| Dec 31, 2016 | -3.56% |
| Sep 30, 2016 | -12.45% |
| Jun 30, 2016 | -14.64% |
| Mar 31, 2016 | -16.52% |
| Dec 31, 2015 | 1.22% |
| Sep 30, 2015 | -40.69% |
| Jun 30, 2015 | -3.86% |
| Mar 31, 2015 | -17.45% |
| Dec 31, 2014 | 1.85% |
| Sep 30, 2014 | -7.25% |
| Jun 30, 2014 | -9.97% |
| Mar 31, 2014 | -26.11% |
| Dec 31, 2013 | -4.45% |
| Sep 30, 2013 | -13.52% |
| Jun 30, 2013 | -27.89% |
| Mar 31, 2013 | -36.82% |
| Dec 31, 2012 | -24.92% |
| Sep 30, 2012 | -74.89% |
| Jun 30, 2012 | -62.55% |
| Mar 31, 2012 | -76.62% |
| Dec 31, 2011 | -54.61% |
| Sep 30, 2011 | -72.72% |
| Jun 30, 2011 | -34.53% |
| Mar 31, 2011 | -83.59% |
| Dec 31, 2010 | -63.29% |
| Sep 30, 2010 | -111.99% |
| Jun 30, 2010 | -95.60% |